116 related articles for article (PubMed ID: 15980875)
1. Effects of (2R)-(3-amino-2-fluoropropyl)sulphinic acid (AFPSiA) on transient lower oesophageal sphincter relaxation in dogs and mechanism of hypothermic effects in mice.
Lehmann A; Holmberg AA; Bhatt U; Bremner-Danielsen M; Brändén L; Elg S; Elebring T; Fitzpatrick K; Geiss WB; Guzzo P; Jensen J; Jerndal G; Mattsson JP; Nilsson K; Olsson BM
Br J Pharmacol; 2005 Sep; 146(1):89-97. PubMed ID: 15980875
[TBL] [Abstract][Full Text] [Related]
2. (R)-(3-amino-2-fluoropropyl) phosphinic acid (AZD3355), a novel GABAB receptor agonist, inhibits transient lower esophageal sphincter relaxation through a peripheral mode of action.
Lehmann A; Antonsson M; Holmberg AA; Blackshaw LA; Brändén L; Bräuner-Osborne H; Christiansen B; Dent J; Elebring T; Jacobson BM; Jensen J; Mattsson JP; Nilsson K; Oja SS; Page AJ; Saransaari P; von Unge S
J Pharmacol Exp Ther; 2009 Nov; 331(2):504-12. PubMed ID: 19648470
[TBL] [Abstract][Full Text] [Related]
3. Different in vitro and in vivo profiles of substituted 3-aminopropylphosphinate and 3-aminopropyl(methyl)phosphinate GABA(B) receptor agonists as inhibitors of transient lower oesophageal sphincter relaxation.
Lehmann A; Antonsson M; Aurell-Holmberg A; Blackshaw LA; Brändén L; Elebring T; Jensen J; Kärrberg L; Mattsson JP; Nilsson K; Oja SS; Saransaari P; von Unge S
Br J Pharmacol; 2012 Mar; 165(6):1757-1772. PubMed ID: 21950457
[TBL] [Abstract][Full Text] [Related]
4. Pharmaceutical and analytical characterisation of (2R)-(3-amino-2-fluoropropyl)sulphinic acid, a GABAB receptor agonist.
Sigfridsson K; Andersson T; Nilsson L; Schönbacher V; Wang Y
Eur J Pharm Biopharm; 2007 Jan; 65(1):104-10. PubMed ID: 16962748
[TBL] [Abstract][Full Text] [Related]
5. Effects of GABA agonists on body temperature regulation in GABA(B(1))-/- mice.
Quéva C; Bremner-Danielsen M; Edlund A; Ekstrand AJ; Elg S; Erickson S; Johansson T; Lehmann A; Mattsson JP
Br J Pharmacol; 2003 Sep; 140(2):315-22. PubMed ID: 12970075
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of GABA(B) receptor agonists on swallowing in the dog.
Lehmann A; Bremner-Danielsen M; Brändén L; Kärrberg L
Eur J Pharmacol; 2002 Jul; 448(1):67-70. PubMed ID: 12126973
[TBL] [Abstract][Full Text] [Related]
7. Effects of repeated administration of baclofen on transient lower esophageal sphincter relaxation in the dog.
Lehmann A; Hansson-Brändén L; Kärrberg L
Eur J Pharmacol; 2000 Sep; 403(1-2):163-7. PubMed ID: 10969158
[TBL] [Abstract][Full Text] [Related]
8. Activation of the GABA(B) receptor inhibits transient lower esophageal sphincter relaxations in dogs.
Lehmann A; Antonsson M; Bremner-Danielsen M; Flärdh M; Hansson-Brändén L; Kärrberg L
Gastroenterology; 1999 Nov; 117(5):1147-54. PubMed ID: 10535878
[TBL] [Abstract][Full Text] [Related]
9. Participation of GABAA, GABA(B) receptors and neurosteroids in toluene-induced hypothermia: evidence of concentration-dependent differences in the mechanism of action.
Paez-Martinez N; Aldrete-Audiffred J; Gallardo-Tenorio A; Castro-Garcia M; Estrada-Camarena E; Lopez-Rubalcava C
Eur J Pharmacol; 2013 Jan; 698(1-3):178-85. PubMed ID: 23085024
[TBL] [Abstract][Full Text] [Related]
10. Positive allosteric modulation of native and recombinant gamma-aminobutyric acid(B) receptors by 2,6-Di-tert-butyl-4-(3-hydroxy-2,2-dimethyl-propyl)-phenol (CGP7930) and its aldehyde analog CGP13501.
Urwyler S; Mosbacher J; Lingenhoehl K; Heid J; Hofstetter K; Froestl W; Bettler B; Kaupmann K
Mol Pharmacol; 2001 Nov; 60(5):963-71. PubMed ID: 11641424
[TBL] [Abstract][Full Text] [Related]
11. Rapid and long-lasting tolerance to clomethiazole-induced hypothermia in the rat.
Visser SA; Pozarek S; Martinsson S; Forsberg T; Ross SB; Gabrielsson J
Eur J Pharmacol; 2005 Apr; 512(2-3):139-51. PubMed ID: 15840398
[TBL] [Abstract][Full Text] [Related]
12. Effect of lesogaberan, a novel GABA(B)-receptor agonist, on transient lower oesophageal sphincter relaxations in male subjects.
Boeckxstaens GE; Rydholm H; Lei A; Adler J; Ruth M
Aliment Pharmacol Ther; 2010 Jun; 31(11):1208-17. PubMed ID: 20222915
[TBL] [Abstract][Full Text] [Related]
13. Transient lower esophageal sphincter relaxations in dogs are inhibited by a metabotropic glutamate receptor 5 antagonist.
Jensen J; Lehmann A; Uvebrant A; Carlsson A; Jerndal G; Nilsson K; Frisby C; Blackshaw LA; Mattsson JP
Eur J Pharmacol; 2005 Sep; 519(1-2):154-7. PubMed ID: 16102747
[TBL] [Abstract][Full Text] [Related]
14. Effects of taurine and some structurally related analogues on the central mechanism of thermoregulation: a structure-activity relationship study.
Frosini M; Sesti C; Saponara S; Donati A; Palmi M; Valoti M; Machetti F; Sgaragli G
Adv Exp Med Biol; 2000; 483():273-82. PubMed ID: 11787608
[TBL] [Abstract][Full Text] [Related]
15. Nonpeptide tachykinin receptor antagonists. II. Pharmacological and pharmacokinetic profile of SB-222200, a central nervous system penetrant, potent and selective NK-3 receptor antagonist.
Sarau HM; Griswold DE; Bush B; Potts W; Sandhu P; Lundberg D; Foley JJ; Schmidt DB; Webb EF; Martin LD; Legos JJ; Whitmore RG; Barone FC; Medhurst AD; Luttmann MA; Giardina GA; Hay DW
J Pharmacol Exp Ther; 2000 Oct; 295(1):373-81. PubMed ID: 10992004
[TBL] [Abstract][Full Text] [Related]
16. GABAB1 receptor subunit isoforms exert a differential influence on baseline but not GABAB receptor agonist-induced changes in mice.
Jacobson LH; Bettler B; Kaupmann K; Cryan JF
J Pharmacol Exp Ther; 2006 Dec; 319(3):1317-26. PubMed ID: 16990508
[TBL] [Abstract][Full Text] [Related]
17. In vitro and in vivo characterization of the novel GABAB receptor positive allosteric modulator, 2-{1-[2-(4-chlorophenyl)-5-methylpyrazolo[1,5-a]pyrimidin-7-yl]-2-piperidinyl}ethanol (CMPPE).
Perdona' E; Costantini VJ; Tessari M; Martinelli P; Carignani C; Valerio E; Mok MH; Zonzini L; Visentini F; Gianotti M; Gordon L; Rocheville M; Corsi M; Capelli AM
Neuropharmacology; 2011; 61(5-6):957-66. PubMed ID: 21756923
[TBL] [Abstract][Full Text] [Related]
18. Neurochemical and functional characterization of the preferentially selective dopamine D3 agonist PD 128907.
Pugsley TA; Davis MD; Akunne HC; MacKenzie RG; Shih YH; Damsma G; Wikstrom H; Whetzel SZ; Georgic LM; Cooke LW
J Pharmacol Exp Ther; 1995 Dec; 275(3):1355-66. PubMed ID: 8531103
[TBL] [Abstract][Full Text] [Related]
19. In vitro and in vivo properties of 3-tert-butyl-7-(5-methylisoxazol-3-yl)-2-(1-methyl-1H-1,2,4-triazol-5-ylmethoxy)-pyrazolo[1,5-d]-[1,2,4]triazine (MRK-016), a GABAA receptor alpha5 subtype-selective inverse agonist.
Atack JR; Maubach KA; Wafford KA; O'Connor D; Rodrigues AD; Evans DC; Tattersall FD; Chambers MS; MacLeod AM; Eng WS; Ryan C; Hostetler E; Sanabria SM; Gibson RE; Krause S; Burns HD; Hargreaves RJ; Agrawal NG; McKernan RM; Murphy MG; Gingrich K; Dawson GR; Musson DG; Petty KJ
J Pharmacol Exp Ther; 2009 Nov; 331(2):470-84. PubMed ID: 19704033
[TBL] [Abstract][Full Text] [Related]
20. The GABA(B) receptor agonist AZD9343 inhibits transient lower oesophageal sphincter relaxations and acid reflux in healthy volunteers: a phase I study.
Beaumont H; Smout A; Aanen M; Rydholm H; Lei A; Lehmann A; Ruth M; Boeckxstaens G
Aliment Pharmacol Ther; 2009 Nov; 30(9):937-46. PubMed ID: 19650825
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
